Na cava na ibalebale ni “Matata”?
Na manumanu e sega ni kauta na veisau. Ena sega ni vakatubura na mate . ka na sega ni vakadewataka yani.
Koli Mataqali 2 ni Labrador (ACHM2-LR)
Achromatopsia Type 2 (ACHM2) in Labrador Retrievers is a genetic condition causing complete color blindness and vision impairment. This DNA test identifies carriers and affected dogs, helping breeders make informed decisions to reduce the risk of passing ACHM2 to puppies. Early detection through genetic testing ensures better management and care for affected Labradors. By using the ACHM2 DNA test, breeders promote healthier bloodlines and improve the overall quality of life for their dogs. This test is essential for responsible Labrador Retriever breeding programs focused on eye health. Protect your Labrador’s vision with accurate ACHM2 genetic screening today. Stay informed and support canine genetic health with reliable DNA testing services.
Vakalekalekataki : ACHM2-LR
Vakadikevi na veisau : CNGA3 c.1931_1933del
Ivotavota : Veisau ni veivakaduiduitaki
Na vosa lekaleka
ACHM2-LR
Vakawasoma ni raici
Na bibi ni valenibula
Veiwasewase vakavuniwai
Mate ni Mata
Vakadikevi na veisau
CNGA3 c.1931_1933del
p.(V644del)
p.(V644del)
Na ivakarau ni ivotavota
Veisau ni veivakaduiduitaki (Taucoko)
Vakalekalekataki ni veivakatovolei:
Achromatopsia Type 2 (ACHM2) in Labrador Retrievers is a genetic condition causing complete color blindness and light sensitivity. This inherited disorder affects the cone cells in the retina, leading to vision problems from an early age. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through genetic testing is crucial for managing the health and well-being of affected Labradors. Responsible breeding can reduce the incidence of ACHM2 in future generations.
E rawa mai na pakete : Basic
Na veivakatovolei ni DNA oqo e okati me tekivu mai na noda pakete . Basic — ka sa tiki talega ni pakete . Basic, Standard, Advanced, Complete.
Raica na DNA ni veivakatovolei ni Pakete →Digitaka na pakete e veiganiti vinaka duadua kei na nomu vakasucu se iwalewale ni bula ni nomu manumanu.
Introduction to Achromatopsia Type 2 in Labrador Retrievers
Achromatopsia Type 2 (ACHM2) is a genetic eye disorder that affects the vision of Labrador Retrievers. This condition results from mutations in the CNGB3 gene, which plays a crucial role in the function of photoreceptor cells in the retina. Affected dogs exhibit a range of visual impairments, primarily characterized by a lack of color vision and sensitivity to bright light.
Clinical Signs of ACHM2
Dogs with Achromatopsia Type 2 typically demonstrate several noticeable symptoms. These may include photophobia (aversion to bright light), nystagmus (involuntary eye movement), and reduced visual acuity. Owners may observe their pets having difficulty navigating in brightly lit environments or showing signs of discomfort in sunlight. The condition often leads to a significant reduction in the quality of life, as affected dogs may struggle with everyday activities.
Genetic Basis of ACHM2
The underlying cause of Achromatopsia Type 2 is linked to genetic mutations in the CNGB3 gene, which is essential for the normal functioning of cone photoreceptors in the retina. These photoreceptors are responsible for color vision and visual clarity. When the CNGB3 gene is mutated, it disrupts the normal signaling pathways, leading to the characteristic symptoms of achromatopsia. The condition follows an autosomal recessive inheritance pattern, meaning that both parents must carry the mutated gene for the offspring to be affected.
Diagnosis of ACHM2
Diagnosis of Achromatopsia Type 2 is typically confirmed through genetic testing. A DNA test can identify the presence of mutations in the CNGB3 gene, providing a definitive diagnosis. Early identification of the condition is crucial for managing the visual challenges faced by affected Labrador Retrievers. Regular veterinary check-ups and consultations with a veterinary ophthalmologist can help monitor the progression of the disease and address any complications that may arise.
Management and Care for Affected Dogs
While there is no cure for Achromatopsia Type 2, management strategies can help improve the quality of life for affected Labrador Retrievers. Owners are encouraged to create a safe and accommodating environment, minimizing exposure to bright lights and ensuring that their pets have a clear understanding of their surroundings. Additionally, training and behavioral modifications can assist these dogs in adapting to their visual limitations, allowing them to navigate their environments more confidently.
Ivakamacala
Achromatopsia Type 2 is a significant genetic condition that affects the vision of Labrador Retrievers, resulting in challenges related to color perception and light sensitivity. Understanding the genetic basis and symptoms of this condition is vital for dog owners and breeders alike. With appropriate management and care, affected dogs can lead fulfilling lives despite their visual impairments.
Breed kilai me baleta na veivakatovolei : Mataqali 2 ni Labrador (ACHM2-LR)
- Labrador Retriever
🧬 Interpretation of genotypes ACHM2-LR
Na mataqali
ITuvatuva
🟡 N/N
Sega ni kauta - Sega na Risiko
🟡 N/ACHM2-LR
Kauta - Sega na Risiko
❌ ACHM2-LR/ACHM2-LR
Vakaleqai - Ena Risiko
FAQ: kila na kena vakadewataki
E bibi beka e dua na “Kauta”?
Sega. E bulabula vinaka na manumanu ia e rawa ni vakadewataka na veisau ina kena . na kawa.
Vakacava ke “Vakacacani” e dua na manumanu?
E kauta mai e rua na ilavelave sa veisautaki. Na ivakatakilakila ni valenibula e namaki me vakatau ena . na mate. E sega ni dodonu me vakasucumi.
Na cava e duidui kina na tagane / yalewa?
Eso na mate e veisemati kei na veiyacovi, e duidui gona na kena vakaraitaki me vakatau ena . na veiyacovi ni manumanu.
Tukuna na Kawa
N/N (sega-ni-kauta)
N/ACHM2-LR (Kauta)
ACHM2-LR/ACHM2-LR (Vakaleqai)
FAQ ni veivakatovolei ni DNA
Na cava e laurai ena veivakatovolei ni DNA oqo?
This DNA test detects the mutation associated with Achromatopsia Type 2 In Labrador Retriever (ACHM2-LR) in order to identify clear, carrier, or at-risk animals.
Na cava me vakatovolei kina e dua na manumanu vakasucu?
Na veivakatovolei ni DNA e vukei ira na dau susu manumanu mera tuvanaka na veiwatini taqomaki ka vakalailaitaka na leqa ni kena vakadewataki na veisau vei ira na luvedra.
Na cava na ivakarau ni ivotavota ni veivakatovolei oqo?
Na ivakarau ni ivotavota e ripotetaki me baleta na veivakatovolei oqo sa ikoya na Veivakalesuimai ni Autosomal.
Na veisau cava e vakadikevi ena veivakatovolei oqo?
This test analyses the mutation CNGA3 c.1931_1933del.
E dodonu beka me vakaleqai e dua na manumanu dau kauta?
Sega ni dodonu. Na kena vakadewataki e vakatau ena ivakarau ni ivotavota kei na genotype e rawa mai kina.
Veidusimaki
Tanaka Naoto, Dutrow Emily V, Miyadera Keiko, Delemotte Lucie, MacDermaid Christopher M, Reinstein Shelby L, Crumley William R, Dixon Christopher J, Casal Margret L, Klein Michael L, Aguirre Gustavo D, Tanaka Jacqueline C, Guziewicz Karina E. Canine CNGA3 Gene Mutations Provide Novel Insights into Human Achromatopsia-Associated Channelopathies and Treatment. PLoS One. 2015 Sep 25;10(9):e0138943. doi: 10.1371/journal.pone.0138943. eCollection 2015.